Insmed Inc (INSM)
27.44
+0.10
(+0.37%)
USD |
NASDAQ |
Mar 28, 11:45
Insmed Stock Buybacks (Quarterly): -114.46M for Dec. 31, 2023
Stock Buybacks (Quarterly) Chart
Historical Stock Buybacks (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | -114.46M |
September 30, 2023 | 0.00 |
June 30, 2023 | -38.01M |
March 31, 2023 | |
December 31, 2022 | -258.77M |
September 30, 2022 | -33.38M |
June 30, 2022 | 0.00 |
March 31, 2022 | |
December 31, 2021 | 0.00 |
September 30, 2021 | 0.00 |
June 30, 2021 | -269.89M |
March 31, 2021 | |
December 31, 2020 | -0.001M |
September 30, 2020 | 0.047M |
June 30, 2020 | -245.91M |
March 31, 2020 | |
December 31, 2019 | 0.00 |
September 30, 2019 | 0.104M |
June 30, 2019 | -261.18M |
March 31, 2019 | |
December 31, 2018 | |
September 30, 2018 | 0.00 |
June 30, 2018 | 0.00 |
March 31, 2018 | |
December 31, 2017 | 0.047M |
Date | Value |
---|---|
September 30, 2017 | -377.70M |
June 30, 2017 | |
March 31, 2017 | |
December 31, 2016 | 0.00 |
September 30, 2016 | 0.00 |
June 30, 2016 | |
March 31, 2016 | |
December 31, 2015 | 0.00 |
September 30, 2015 | 0.00 |
June 30, 2015 | -222.94M |
March 31, 2015 | |
December 31, 2014 | -0.997M |
September 30, 2014 | -108.02M |
June 30, 2014 | 0.00 |
March 31, 2014 | |
December 31, 2013 | 0.00 |
September 30, 2013 | -67.02M |
June 30, 2013 | |
March 31, 2013 | |
December 31, 2012 | 0.001M |
September 30, 2012 | -25.66M |
June 30, 2012 | |
March 31, 2012 | |
December 31, 2011 | 0.032M |
September 30, 2011 | 0.00 |
Stock Buyback Definition
Stock buybacks are when companies buy back their own stock, removing it from the marketplace. Stock buybacks increase the value of the remaining shares because there is now less common stock outstanding and company earnings are split among fewer shares.
Stock Buybacks (Quarterly) Range, Past 5 Years
-269.89M
Minimum
Jun 2021
0.104M
Maximum
Sep 2019
-81.43M
Average
-0.001M
Median
Dec 2020
Stock Buybacks (Quarterly) Benchmarks
NeuroMetrix Inc | -1.624M |
Intra-Cellular Therapies Inc | 0.00 |
Rhythm Pharmaceuticals Inc | 0.00 |
Amylyx Pharmaceuticals Inc | 0.00 |
AN2 Therapeutics Inc | -65.80M |